CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma
Yang Wu(Chinese Academy of Sciences), Haojie Jin(Zhejiang University of Technology)
Cited by 1
Related Papers
Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice
|Hepatology|2021|229